Analysis of anemia in elderly patients with chronic heart failure and its influencing factors#br#
CHENG Changsheng1 CAI Wenjuan1 CAO Huiling2
1.Outpatient and Emergency Center, Jiangsu Province Hospital of Traditional Chinese Medicine, Jiangsu Province, Nanjing 210029, China;
2.Department of Laboratory, Jiangsu Province Hospital of Traditional Chinese Medicine, Jiangsu Province, Nanjing 210029, China
Abstract：Objective To investigate the anemia and its influencing factors in elderly patients with chronic heart failure. Methods A total of 1275 elderly patients with chronic heart failure diagnosed and treated in Jiangsu Province Hospital of Traditional Chinese Medicine from March to September 2018 were selected and divided into non-anemia group (946 cases) and anemia group (329 cases) according to hemoglobin ＜120 g/L (male) or <110 g/L (female). The general data and clinical data of the two groups were compared to analyze the influencing factors of anemia in elderly patients with chronic heart failure. Results A total of 329 (25.8%) elderly patients with chronic heart failure complicated with anemia, including 167 cases of mild anemia, 98 cases of moderate anemia, 64 cases of severe anemia. The causes of anemia were iron deficiency anemia in 241 cases, renal anemia in 34 cases, megaloblastic anemia in 27 cases, and anemia of other causes in 27 cases. Age, course of heart failure, proportion of New York Heart Association (NYHA) grade Ⅲ to Ⅳ, proportion of complicated chronic kidney disease, average number of hospitalization, and length of hospitalization for heart failure within one year in anemia group were higher than those in non-anemia group, the differences were statistically significant (P ＜ 0.05). The results of multivariate analysis showed that education level, albumin level, heart failure course, and NYHA grade were the influencing factors of anemia in elderly patients with chronic heart failure (P ＜ 0.05). Conclusion Anemia in elderly patients with chronic heart failure may be related to their educational level, albumin level, heart failure course, and NYHA grade.
成昌盛1 蔡文娟1 曹慧玲2. 老年慢性心力衰竭患者合并贫血情况及其影响因素分析[J]. 中国医药导报, 2022, 19(8): 60-63.
CHENG Changsheng1 CAI Wenjuan1 CAO Huiling2. Analysis of anemia in elderly patients with chronic heart failure and its influencing factors#br#. 中国医药导报, 2022, 19(8): 60-63.
[1] Enjuanes C，Klip IT，Bruguera J，et al. Iron deficiency and health-related quality of life in chronic heart failure：results from a multicenter European study [J]. Int J Cardiol，2014，174（2）：268-275.
[2] 范东娜.重组人促红细胞生成素对老年慢性心力衰竭合并贫血病人心功能及运动耐量的影响[J].中西医结合心脑血管病杂志，2019，17（2）：312-313.
[3] Sabah Z，Aziz S，Wani J，et al. The association of anemia as a risk of heart failure [J]. J Family Med and Prim Care，2020，9（2）：839-843.
[4] 蔡海清.长护险试点地区待遇保障政策比较分析[J].中国医院院长，2021，17（10）：68-71.
[5] 中华医学会心血管病学分会心力衰竭学组.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志，2018，46（10）：760-789.
[6] 陈灏珠，钟南山，陆再英.内科学[M].8版.北京：人民卫生出版社，2017：543-548.
[7] 穆林，吴永全.铁缺乏对老年慢性心力衰竭患者左心结构的影响[J].中华老年心脑血管病杂志，2019，21（7）：703-706.
[8] Cleland JG，Zhang J，Pellicori P，et al. Prevalence and Outcomes of Anemia and Hematinic Deficiencies in Patients With Chronic Heart Failure [J]. JAMA Card，2016，1（5）：539-547.
[9] Mordi IR，Tee A，Lang CC. Iron therapy in heart failure：ready for primetime [J]. Card Fail Rev，2018，4（1）：28-32.
[10] Lam CSP，Doehner W，Comin-Colet J，et al. Iron deficiency in chronic heart failure：case-based practical guidance [J]. ESC Heart Fail，2018，5（5）：761-771.
[11] Makubi A，Hage C，Sartipy U，et al. Heart failure in Tanzania and Sweden：Comparative characterization and prognosis in the Tanzania Heart Failure（TaHeF）study and the Swedish Heart Failure Registry（SwedeHF）[J]. Int J Cardiol，2016，220（1）：750-758.
[12] Cappellini MD，Comin-Colet J，de Francisco A，et al. Iron deficiency across chronic inflammatory conditions：international expert opinion on definition，diagnosis and management [J]. Am J Hematol，2017，92（10）：1068-1078.
[13] González-Costello J，Comín-Colet J，Lupón J，et al. Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations：insights from an observational cohort study [J]. BMC Cardiovascular Disorders，2018，18（1）：206-217.
[14] Ponikowski P，van Veldhuisen DJ，Comin-Colet J，et al. Rationale and design of the CONFIRM-HF study：a double-blind，randomized，placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency [J]. ESC Heart Fail，2014，1（1）：52-58.
[15] Bourguignon S，Faller M，Champs F，et al. Budget impact of intravenous ferric carboxymaltose in patients with chronic heart failure and iron deficiency in France [J]. ESC Heart Failure，2019，6（3）：559-569.
[16] Paterek A，K?誰pska M，Sochanowicz B，et al. Beneficial effects of intravenous iron therapy in a rat model of heart failure with preserved systemic iron status but depleted intracellular cardiac stores [J]. Sci Rep，2018，8（1）：15758.
[17] Saba H，Wang Y，Bruno G，et al. Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure [J]. Eur Heart J，2017，38（5）：362-372.
[18] Gstrein C，Meyer M，Anabitarte P. Iron substitution in the treatment of chronic heart failure [J]. Swiss Med Wkly，2017，147：w14453.
[19] Sirbu O，Floria M，Dascalita P，et al. Anemia in heart failure from guidelines to conlroversies and challenges [J]. Anatol J Cardi01，2018，20（1）：52-59.
[20] 邓淑玲，吕明义，龙晓凤.左卡尼汀联合促红细胞生成素对老年慢性心衰合并贫血患者心功能的改善效果研究[J].中国实用医药，2020，15（32）：108-110.
[21] 马菊宁，刘璐，陈卓，等.慢性心力衰竭合并贫血中西医治疗研究进展[J].中国医药导报，2020，17（24）：28-31.
[22] Strobeck JE，Feldschuh J，Miller WL，et al. Heart Failure Outcomes With Volume-Guided Management [J]. JACC Heart Fail，2018，6（11）：940-948.
[23] 王华，李莹莹，柴坷，等.中国住院心力衰竭患者流行病学及治疗现状[J].中华心血管病杂志，2019，47（11）：865-874.
[24] 沙敏，姜桂环，孙巧梅，等.贫血标志物在慢性心力衰竭治疗中的临床应用的研究[J].心理月刊，2019，14（18）：168-169.
[25] 杨艳华，黄姣红，安芳，等.贫血对慢性心力衰竭住院患者预后影响的回顾性分析[J].中华灾害救援医学，2020， 8（12）：664-667.
京公网安备 11010502046598号